Opioid δ-receptor agonists show promise for treating IBS-like symptoms

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and reducing stress-induced hypermotility.

Ketamine’s rapid impact on depression linked to immune system pathways

Study reveals ketamine’s potent anti-inflammatory effects on neurological disorders, showing promise for treating major depressive disorder through modulation of neuroimmune pathways.

April 15, 2024

Philips will pay $1.1 billion to resolve U.S. lawsuits over breathing machines that expel debris

WASHINGTON — Medical device maker Philips said Monday it will pay $1.1 billion to settle hundreds of personal injury lawsuits in the U.S. over its

April 29, 2024

Startup’s fast-acting wound treatment gel gets FDA nod for use in humans

Dive Brief: Cresilon has received 510(k) clearance from the U.S. Food and Drug Administration for a gel that is designed to quickly stop bleeding when

July 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.